Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Leukemia, Hairy Cell × Clear all

Status

Completed 123 Terminated 39 Recruiting 19 Active not recruiting 9 Withdrawn 8 Unknown 8 Not yet recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 11 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 8 Prostatic Neoplasms 7 Multiple Myeloma 6 Breast Neoplasms 6 Leukemia, Myeloid, Acute 4 Small Cell Lung Carcinoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Lambert-Eaton Myasthenic Syndrome 3 HER2-positive Breast Cancer 3 Glioma 3 Thyroid Neoplasms 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Myasthenic Syndromes, Congenital 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2

Interventions

immunotoxin HA22 1 HA 22 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡